Topsoe’s Syncor technology will be licensed for Sandpiper Chemicals’ new blue methanol plant in Texas, USA. The project is expected to produce 3,000 metric tons per day of blue methanol on completion.

The latest Version 1.34 of pngate PA now includes support for the ABB Field Information Manager (ABB FIM) asset management tool. This extends compatibility with a widely used solution for managing Profibus PA field devices.

Metso has been selected by Maaden to supply a gold processing plant for its Ar Rjum mine located in Saudi Arabia. The order value is approximately 128 million euros.

The pilot plant has the capacity to recycle complex waste streams from end-of-life vehicles via chemical recycling in order to produce raw materials for new vehicle components such as foam for steering wheels.

Beijing Shougang International Engineering Technology pilots BIM workflows to deliver a seawater desalination project for Wanhua Chemical. The engineering company made use of Bentley’s open applications to shorten design by 50 % while supporting intelligent plant operations.

The global investment firm Carlyle has signed a binding transaction agreement with BASF to secure a majority stake in its coating business. The transaction is expected to close in Q2 2026.

Offering high-quality recycled polypropylene and polyethylene materials, the new compounding line by Borealis is now fully operational in Belgium. The line makes use of Borealis’ proprietary Borcycle M mechanical recycling technology.

Durabook has launched R10, a next-generation AI-powered fully rugged tablet that is equipped with high-performance Intel Core Ultra 200V series processors. The device is claimed to be one of the first Copilot+ PC rugged tablets in the market.

With an aim to advance its worldwide circular silica strategy, Solvay has plans to convert its highly dispersible silica production in Asia to circular raw materials. The move is expected to enable tire makers to adopt circular materials at scale.

GSK’s mega investment includes a new 1.2-billion-dollar investment in advanced manufacturing facilities and AI and advanced digital technologies. With this, the company aims to develop new, next-generation biopharma factories and laboratories in the USA.